Filmed at Lilly’s Erl Wood at 50 celebration event, Sue Forda (Lilly, UK) shares highlights from Erl Wood’s 50-year history, and discusses Lilly’s current research priorities in the neuroscience field and what the next 50 years could hold.
Sue Forda is Vice President, Global Regulatory Affairs with Lilly and is responsible for all European and Intercontinental regulatory aspects of the company’s current and future products. Sue initially trained as a pharmacist, then, after completing a PhD in neuropharmacology, worked as a post-doctoral research fellow at St George’s Hospital Medical School, University of London. She later joined Beecham, subsequently SmithKline Beecham Pharmaceuticals, in their Worldwide Regulatory Affairs Department where over a nine-year period, she held various positions. In May 2003 Sue was awarded an MSc in the Economic Evaluation of Healthcare. Sue leads a number of regulatory initiatives for the European Federation of Pharmaceutical Industries and Associations (EFPIA).
This content has been financially supported by Lilly.